Citius Pharmaceuticals CTXR
NASDAQ CTXR
$0.37 -0.03 (-6.69%)
As of: Oct 22, 2026 · 12:36 PM EDT

Citius Pharmaceuticals (CTXR) FCF Margin (2014 - 2026)

Updated

Citius Pharmaceuticals' FCF Margin was -581.82% in fiscal Q3 2026 (quarter ended Jun 30, 2026), down 503.85 percentage points from the prior quarter.

Analysis

Citius Pharmaceuticals (CTXR) FCF Margin (2014 - 2026) Analysis & Trends

On a trailing twelve-month basis, Citius Pharmaceuticals' FCF Margin was -490.92% through Jun 30, 2026.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Eli Lilly 1,170.90 Bn 1,139.49 Bn 19.71 Bn 33.76%
2 Johnson & Johnson 643.26 Bn 561.78 Bn 17.26 Bn 28.82%
3 AbbVie 501.85 Bn 474.96 Bn 12.70 Bn 18.33%
4 Merck 370.72 Bn 325.10 Bn 12.21 Bn 26.96%
5 Novartis Ag 302.56 Bn 266.55 Bn 11.24 Bn 38.60%
6 Astrazeneca 268.35 Bn 242.04 Bn 12.86 Bn 6.55%
7 Amgen 242.39 Bn 197.79 Bn 7.24 Bn 34.70%
8 Gilead Sciences 193.22 Bn 167.42 Bn 6.22 Bn 44.00%
9 Pfizer 172.25 Bn 118.90 Bn 10.94 Bn 2.01%
10 Citius Pharmaceuticals 9.69 Mn -23.88 Mn 1.00 Mn -581.82%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -581.82%
Mar 31, 2026 -77.97%
Dec 31, 2025 -329.83%
Sep 30, 2016 -29,449,800.00%
Jun 30, 2016 -327,608.06%
Mar 31, 2016 -29,148,400.00%
Dec 31, 2015 -4,647,240.00%
Sep 30, 2015 -624,159.29%
Jun 30, 2015 -210,876.17%
Mar 31, 2015 -70,890.83%
Dec 31, 2014 -33,280.03%
API Access

Citius Pharmaceuticals FCF Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=fcf-margin&ticker=CTXR&period=max&api_key=YOUR_API_KEY